David Spiegel, M.D.
Jack, Lulu & Sam Willson Professor in the School of Medicine
Associate Chair: Department of Psychiatry and Behavioral Sciences
401 Quarry Road
Stanford, CA 94305-5718 USA
See Curriculum Vitae for professional data and publications.
Dr. David Spiegel is the recipient of an endowed chair: Jack, Lulu & Sam Willson Professor in the School of Medince Professor and he is Associate Chair of Psychiatry and Behavioral Sciences, both at Stanford University School of Medicine where he has been a member of the academic faculty since 1975 and is Director of the Psychosocial Research Laboratory. He received his bachelorís degree in philosophy at Yale and his medical and psychiatric training at Harvard prior to coming to Stanford. He is the author of over 350 research papers, chapters in scientific journals, and books.
Dr. Spiegel is a leader in the field of psychosomatic research, treatment and development with particular interest in the field of psychoneuroendocrinology/oncology.
Since beginning research on the effects of support groups for women with metastatic breast cancer in 1976, Dr. Spiegel has published numerous studies showing that group psychotherapeutic interventions have positive effects on mood disturbance, coping and pain among these patients. He is the author of a landmark study, Effect of psychosocial
treatment on survival of patients with metastatic breast cancer (The Lancet; October 14, 1989; 888-891, see abstract), a randomized prospective clinical trial which studied the effects of psychotherapeutic intervention in women with metastatic breast cancer. This study demonstrated that the application of supportive-expressive group therapy in women with terminal disease not only improved quality of life, but significantly enhanced survival time. This research used a rigorous scientific methodology to address large and important questions regarding the relationship between psychosocial and biological variables in breast cancer and possible mechanisms through which they may be related, and has spawned a new line of research on the health effects of psychosocial support. This work was the subject of a segment on the Bill Moyers' Emmy Award-winning special Healing and the Mind.
|demonstrated that |
|the application of |
|   group therapy in women   |
|with terminal disease |
|not only improved |
|quality of life, |
|but significantly |
|enhanced survival time|
His laboratory is currently completing a replication trial to determine whether or not Supportive/Expressive group psychotherapy results in longer survival time in a sample of 125 women with metastatic breast cancer. This trial is funded by the National Institute of Mental Health (NIMH) and the National Cancer Institute (NCI). An independent multi-center replication trial is being conducted in Canada under the direction of Dr. Pamela Goodwin, medical oncologist at Mt. Sinai Hospital in Toronto in a sample 225 women with advanced breast cancer. Dr. Spiegel is also directing trials of the effects of group psychotherapy for women with recently diagnosed breast cancer (a multicenter trial with the Community Clinical Oncology Program, sponsored by NCI) and for men and women with HIV infection (sponsored by NIMH).
His book, Living Beyond Limits: New Hope and Help for Facing Life-Threatening Illness (Ballantine/Fawcett, 1994) is a careful description of his fifteen years of experience in helping patients with advanced cancer cope with their illness. Consistent themes are examined,
including the importance of forming strong bonds of mutual support, facing fears of dying and death directly, reordering life priorities, managing relationships with family, friends, and physicians, and learning to control pain and other symptoms with self-hypnosis. The book describes his pioneering study with metastatic breast cancer patients, and provides sensible guidelines for those women living with this illness and their families. Dr. Spiegel has developed a long overlooked area - compassionate supportive care for the medically ill which does not make the error of teaching patients that survival is simply mind over matter. His research has shown, however, that mind matters.
|   Dr. Spiegel has developed   |
|a long overlooked area -|
|care for the medically ill|
|which does not make the|
|error of teaching patients|
|that survival is simply|
|mind over matter|
Dr. Spiegel has long had an interest in the use of hypnosis as treatment for medical symptoms and treatment side effects. In 1978, he and his father, Herbert Spiegel, M.D., co authored what has become a standard textbook on the clinical uses of hypnosis, Trance and Treatment. The use of self-hypnosis to alter help children undergoing painful and embarrassing procedures such as voiding cystourethrograms is among his current research funded by John D. and Catherine T. MacArthur Foundation. In the area of cancer prevention, Dr. Spiegel is currently conducting a large prospective trial of the efficacy of training in self-hypnosis in facilitating smoking cessation. This study will provide information regarding predictors of smoking abstinence and subsequent risk for cancer and other illnesses. He is the past president of the Society for Clinical and Experimental Hypnosis, and in 1986, was the recipient of the Schneck Award for significant contributions to the development of medical hypnosis.
He has studied immediate reactions to life-threatening events, including the 1989 Loma Prieta Earthquake and the 1991 Oakland/Berkeley firestorm, demonstrating that acute dissociative symptoms are strong predictors of the development of later post-traumatic stress disorder. Dr. Spiegel collaborated in the inclusion of Acute Stress Disorder, a new psychiatric diagnosis in the Diagnostic Statistical Manual, Fourth Edition (DSM-IV) as well as serving on the committee for Dissociative Disorders. He is the editor of Dissociation: Culture, Mind and Body (American Psychiatric Press, 1994).
In 1998, Dr. Spiegel opened the Center for Integrative Medicine at Stanford Medical Center, and he serves as its Medical Director. This new program is designed to provide the highest standard of clinical care and research to the utilization of techniques designed to help patients better cope with their illnesses. The program includes careful diagnostic assessment and treatment recommendations, a Cancer Supportive Care Program including nutrition, exercise, and support groups, hypnosis, biofeedback, acupuncture, therapeutic massage, mindfulness meditation, and yoga. For more information about this program, please call 650 498-5566.
In 1997, Dr. Spiegel was the Burroughs Wellcome Visiting Professor, Royal Society of Medicine, United Kingdom, and a Rockefeller Foundation Visiting Scholar at the Bellagio Study and Conference Center in Bellagio, Italy. In 1995, Dr. Spiegel was the recipient of the Edward A. Strecker, M.D. Award, given annually by the Pennsylvania Hospital and the University of Pennsylvania Health System to an individual who has made an outstanding contribution to the field of clinical psychiatry in the United States . In 1993 he received the Treya Killam Wilber Award from the Cancer Support Community. He was given the Kaiser Award and the Academic Faculty Member Residency Program Award for Excellence in Teaching at Stanford University School of Medicine in 1986. He is also a Fellow of the American College of Psychiatrists and the American Psychiatric Association.
His research is supported by a number of leading research and charitable foundations, including the National Institute on Aging, National Institute of Mental Health, National Cancer Institute, American Cancer Society, , Nathan S. Cummings Foundation, the Fetzer Institute, the Charles A. Dana Foundation, and others. His current research involves collaborative efforts with investigators from Canada, Norway, Israel, Australia as well as a variety of medical-surgical specialists, psychiatrists and psychologists from the US.
Dr. Spiegel is a member of the editorial boards of 11 journals including: the Columbia Univ. School. of Public Health Newsletter, The Breast, Consciousness and Cognition, Dissociation, Journal of Traumatic Stress, the Harvard Review of Psychiatry, , The Journal of Psychosocial Oncology, Psycho-Oncology, American Journal of Clinical Hypnosis, Health Psychology, and The International Journal of Clinical and Experimental Hypnosis. In addition he is a Series Editor for Progress in Psychiatry Series, published by American Psychiatric Press, Inc., a new series of books reporting research advances in psychiatry. Fifty volumes have been published in this series to date.